Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells & Cell Therapy Summit

Edward Balbirnie's Biography

Edward Balbirnie, Head, Cellectis

Edward Balbirnie, Ph.D., joined Cellectis in July 2010 as Chief Operations Officer of their stem cell subsidiary, Ectycell and is currently Head of GMP Operations, supporting several exciting clinical programs under development involving stem cell derived products and novel cancer therapies using the Cellectis genome engineering technology.

Dr. Balbirnie has 25 years experience in the pharma and biotech industries in the areas of in-vitro diagnostics, gene and cell therapy and recombinant protein development and manufacture. A Qualified Person, he has most recently held senior management positions in Quality Assurance at Elan (Ireland) and IDM (France) as well as in Bioproduction at LFB Biotechnologies (France).

Edward Balbirnie Image

Clinical Grade iPS Cell Manufacture by Cellectis

Friday, 6 September 2013 at 11:00

Add to Calendar ▼2013-09-06 11:00:002013-09-06 12:00:00Europe/LondonClinical Grade iPS Cell Manufacture by CellectisStem Cells and Cell Therapy Summit in London, UKLondon,

Cellectis, via it's 'iPS Engineering HubTM ' has developed the capability to produce clinical grade iPS cells using GMPs which could be used as starting material for future iPS-based therapeutics.

Add to Calendar ▼2013-09-05 00:00:002013-09-06 00:00:00Europe/LondonStem Cells and Cell Therapy SummitStem Cells and Cell Therapy Summit in London, UKLondon,